Browse Tag

vaccine

First patient in UK given ‘vaccine’ for cancer in pioneering clinical research trial

2 mins read

The FINANCIAL — A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning – in a clinical research trial which may help bring further ground-breaking treatments for the disease.…

Willing but unable to get COVID shot

2 mins read

The FINANCIAL — Study of racial, ethnic disparities in vaccine rates suggests mistrust of system plays role but unequal access may be greater culprit in U.S. People of color in the U.S. and U.K. were up to three times likelier than white people to report being unsure or unwilling to get a COVID-19 shot during the…

Covid-19 Vaccine Protection Wanes After Three Months, Study Suggests

2 mins read

The FINANCIAL — The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says, University of Glasgow says.…

COVID-19 vaccine volunteers share their stories, one year later

3 mins read

The FINANCIAL —  Within the space of one momentous week in December 2020, vaccines to prevent COVID-19 from both Pfizer–BioNTech and Moderna became the first mrRNA vaccines authorized for widespread use, according to University of Pennsylvania.…

Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant

2 mins read

The FINANCIAL — Researchers used blood samples collected from Com-COV2 study participants who had received two doses of standard COVID-19 vaccination schedules to perform neutralisation assays using Omicron virus isolate…

Needle-free vaccine targets COVID-19 variants and future coronaviruses

3 mins read

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.…

Time of day matters when getting vaccine

2 mins read

Antibody levels higher when people receive SARS-CoV-2 vaccine in the afternoon, say researchers. Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination. A new study published in the Journal of Biological Rhythms demonstrates that antibody levels are higher when people receive the SARS-CoV-2 vaccine in the afternoon…

New COVID-19 study for immunocompromised people

3 mins read

The FINANCIAL — A new national study is recruiting immunocompromised people to determine their immune response to COVID-19 vaccination over six months.…

Breaking down boosters

2 mins read

What happens to our immune systems when we get a booster and will COVID boosters stay on the list?…

Kids cleared for COVID-19 vaccination

2 mins read

The FINANCIAL — Providing safe and effective vaccinations to children, especially as they’ve returned to school, is an important step to protect them from getting sick.…

Covid Immunity Through Infection or Vaccination: Are They Equal?

4 mins read

Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need to be vaccinated against covid because he’d fallen ill with the disease in July 2020.…

/

5 Things to Know About the COVID-19 Vaccines

2 mins read

The FINANCIAL —  Vaccines are a critical part of slowing, and eventually stopping, the spread of COVID-19, and Kaiser Permanente is committed to providing you with vaccine information as it’s available.…

Joint COVAX statement on supply forecast for 2021 and early 2022

2 mins read

The FINANCIAL — “Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.”UNICEF notes.…

How Everyday People Help the CDC Track Covid Vaccine Safety With Their Phones

6 mins read

Of the 203 million people who have received at least one dose of a covid-19 vaccine, more than 9 million have enrolled in a program to share information about their health since getting the shot.…

Vaccine for treating cancer made possible using Oxford COVID vaccine technology

3 mins read

The FINANCIAL — Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer. Researchers have designed a two-dose therapeutic cancer vaccine using Oxford’s viral vector vaccine technology.…

1 2 3